GlassScriptPhysician profile
Matias Nauts
NPI 1154616936
$112,240.86
in general payments reported to CMS, 2019-2025
10 companies · $3,686 in 2025
The $3,686 reported for 2025 was more than what 88% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34K · 2020: $11K · 2021: $23K · 2022: $31K · 2023: $8,678 · 2024: $478 · 2025: $3,686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $10K · Food and Beverage: $1,994 · Travel and Lodging: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,038.40 |
| Food and Beverage | $1,993.67 |
| Travel and Lodging | $809.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $111,239.20 | 2019-2025 | Da Vinci Surgical System |
| Integra Lifesciences Corporation | $433.56 | 2020-2021 | |
| Ethicon US, LLC | $258.90 | 2019-2024 | Enseal, Echelon; Endopath, Harmonic |
| Sanara Medtech INC. | $155.61 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $36.96 | 2024-2025 | Exparel, Iovera, Zilretta |
| Kerecis Limited | $30.31 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Qol Medical, LLC | $29.02 | 2023 | Sucraid |
| Medtronic, INC. | $25.07 | 2025 | Progrip |
| Eagle Pharmaceuticals, INC. | $18.18 | 2022 | |
| Novo Nordisk INC | $14.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matias Nauts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.